Mechanical thrombectomy in stroke in nonagenarians: useful or futile?


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 13 05 2020
accepted: 31 05 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 3 11 2020
Statut: ppublish

Résumé

Mechanical thrombectomy is the standard treatment in acute ischemic stroke due to large vessel occlusion, but there is limited evidence about its efficacy in very old patients. We sought to analyse safety and effectiveness of mechanical thrombectomy in nonagenarian versus octagenarian patients. We included consecutive patients with acute ischemic stroke due to large vessel occlusion subjected to mechanical thrombectomy, during 29 months in a tertiary center. Patients were divided into two sub-groups, according to age: 80-89 and >90 years old. Recanalization, complications, functional outcome and mortality at discharge and at 3 months were compared. Multivariable analysis was performed to identify independent predictors of functional outcome at 3 months of follow-up, assessed by the modified Rankin Scale. A total of 128 octogenarians (88.9%) and 16 nonagenarians (11.1%) met the inclusion criteria. Successful revascularization was achieved in 87.5% of octagenarians and in 81.3% of nonagenarians (p = 0.486). Symptomatic hemorrhage occurred in 3.1% and 6.3% of younger and older patients, respectively (p = 0.520). Cerebral edema occured in 35.2% of octagenarians versus 25.0% of nonagenarians (p = 0.419). Functional independence (mRS ≤ 2) at 3 months was achieved in 28 (22.6%) and 5 (31.3%) of octagenarians and nonagenarians, respectively (p = 0.445). Mortality at 3 months was not significantly higher in nonagenarians (37.5%) versus octagenarians (33.9%, p = 0.773). No significant diferences were found in functional outcome, mortality, recanalization and complication rates between octagenarians and nonagenarians submitted to mechanical thrombectomy, underlining that patients should not be excluded from mechanical thrombectomy based on age alone.

Sections du résumé

BACKGROUND BACKGROUND
Mechanical thrombectomy is the standard treatment in acute ischemic stroke due to large vessel occlusion, but there is limited evidence about its efficacy in very old patients. We sought to analyse safety and effectiveness of mechanical thrombectomy in nonagenarian versus octagenarian patients.
METHODS METHODS
We included consecutive patients with acute ischemic stroke due to large vessel occlusion subjected to mechanical thrombectomy, during 29 months in a tertiary center. Patients were divided into two sub-groups, according to age: 80-89 and >90 years old. Recanalization, complications, functional outcome and mortality at discharge and at 3 months were compared. Multivariable analysis was performed to identify independent predictors of functional outcome at 3 months of follow-up, assessed by the modified Rankin Scale.
RESULTS RESULTS
A total of 128 octogenarians (88.9%) and 16 nonagenarians (11.1%) met the inclusion criteria. Successful revascularization was achieved in 87.5% of octagenarians and in 81.3% of nonagenarians (p = 0.486). Symptomatic hemorrhage occurred in 3.1% and 6.3% of younger and older patients, respectively (p = 0.520). Cerebral edema occured in 35.2% of octagenarians versus 25.0% of nonagenarians (p = 0.419). Functional independence (mRS ≤ 2) at 3 months was achieved in 28 (22.6%) and 5 (31.3%) of octagenarians and nonagenarians, respectively (p = 0.445). Mortality at 3 months was not significantly higher in nonagenarians (37.5%) versus octagenarians (33.9%, p = 0.773).
CONCLUSIONS CONCLUSIONS
No significant diferences were found in functional outcome, mortality, recanalization and complication rates between octagenarians and nonagenarians submitted to mechanical thrombectomy, underlining that patients should not be excluded from mechanical thrombectomy based on age alone.

Identifiants

pubmed: 32807430
pii: S1052-3057(20)30433-X
doi: 10.1016/j.jstrokecerebrovasdis.2020.105015
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105015

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Mafalda Mendes Pinto (MM)

Functional Area of Neuroradiology, Medical Imaging Department - Centro Hospitalar Universitário de Coimbra.

Ana Paiva Nunes (AP)

Cerebrovascular Unit - Hospital de São José, Centro Hospitalar Universitário de Lisboa Central.

Marta Alves (M)

Epidemiological Analysis and Statistics Department - Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa.

Ana Luísa Papoila (AL)

Epidemiological Analysis and Statistics Department - Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa.

Jaime Pamplona (J)

Neuroradiology Department - Hospital de São Jose, Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa.

Rui Carvalho (R)

Neuroradiology Department - Hospital de São Jose, Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa.

Mariana Baptista (M)

Neuroradiology Department - Hospital de São Jose, Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa.

João Reis (J)

Neuroradiology Department - Hospital de São Jose, Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa.

Isabel Fragata (I)

Neuroradiology Department - Hospital de São Jose, Centro Hospitalar Universitário de Lisboa Central; Faculdade de Ciências Médicas/NOVA Medical School, Universidade Nova de Lisboa. Electronic address: isabel.fragata2@chlc.min-saude.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH